The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Bloodstream Infections by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome
Open accessAbstract
To determine the epidemiologic features and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates, cases of bacteremia caused by these organisms in children were analyzed retrospectively. Among the 157 blood isolates recovered from 1993 to 1998 at the Seoul National University Children's Hospital, the prevalence of ESBL production was 17.9% among the E. coli isolates and 52.9% among the K. pneumoniae isolates. The commonest ESBLs were SHV-2a and TEM-52. A novel ESBL, TEM-88, was identified. Pulsed-field gel electrophoresis analysis of the ESBL-producing organisms showed extensive diversity in clonality. The medical records of 142 episodes were reviewed. The risk factors for bloodstream infection with ESBL-producing organisms were prior hospitalization, prior use of oxyimino-cephalosporins, and admission to an intensive care unit within the previous month. There was no difference in clinical severity between patients infected with ESBL-producing strains (the ESBL group) and those infected with ESBL-nonproducing strains (the non-ESBL group) at the time of presentation. However, the overall fatality rate for the ESBL group was significantly higher than that for the non-ESBL group: 12 of 45 (26.7%) versus 5 of 87 (5.7%) ( P = 0.001). In a subset analysis of patients treated with extended-spectrum cephalosporins with or without an aminoglycoside, favorable response rates were significantly higher in the non-ESBL group at the 3rd day (6 of 17 versus 33 of 51; P = 0.035), the 5th day (6 of 17 versus 36 of 50; P < 0.05), and the end of therapy (9 of 17 versus 47 of 50; P < 0.001). In conclusion, the ESBL production of the infecting organisms has a significant impact on the clinical course and survival of pediatric patients with bacteremia caused by E. coli and K. pneumoniae .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Jarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,559
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 912
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
The Use of Analytical Isoelectric Focusing for Detection and Identification of -Lactamases
MATTHEW, M., HARRIS, A. M., MARSHALL, M. J., & ROSS, G. W. (1975) · Journal of General Microbiology · doi:10.1099/00221287-88-1-169 · Cited by 688
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Gautom, R. K. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2977-2980.1997 · Cited by 513
Enterobacteriaceae : introduction and identification
Farmer, J. J. (1995) · Medical Entomology and Zoology · Cited by 472
Molecular biotechnology: principles and applications of recombinant DNA
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4487 · Cited by 444
Killing and regrowth of bacteria in vitro: a review.
Craig, W. A., & Ebert, S. C. (1990) · PubMed · Cited by 303
Jacoby, G. A., & Han, P. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.908-911.1996 · Cited by 295
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Ernst, S., & Casellas, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.509 · Cited by 220
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Self-citationIshii, Y., Ohno, A., Taguchi, H., Imajo, S., Ishiguro, M., & Matsuzawa, H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2269 · Cited by 205
Gram-positive resistance: challenge for the development of new antibiotics
Baquero, F. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.suppl_1.1 · Cited by 195
Jackson, J. J., & Kropp, H. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.6.1033 · Cited by 183
Pai, H., Choi, E. H., Lee, H.-J., Hong, J. Y., & Jacoby, G. A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3747-3749.2001 · Cited by 135
Self-citationGenetics of extended-spectrum beta-lactamases
Jacoby, G. A. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02390679 · Cited by 133
Trends in β‐Lactam Resistance Among Enterobacteriaceae
Nordmann, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514905 · Cited by 124
Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins
Bauernfeind, A., & Hörl, G. (1987) · Infection · doi:10.1007/bf01644127 · Cited by 105
Danel, F., Hall, L. M., Gür, D., & Livermore, D. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.785 · Cited by 90
Rice, L. B., Carias, L. L., Bonomo, R. A., & Shlaes, D. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.151 · Cited by 57
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Self-citation
Metadata
- Authors
- Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-05
- Volume
- 46
- Issue
- 5
- Pages
- 1481-1491
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2159585072
- Cited by
- 357
- References
- 27
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.